Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Technology for Sampling Body Liquids in Confined Spaces to Enable Early Cancer Detection

By LabMedica International staff writers
Posted on 17 Sep 2024

Body fluids—such as blood, pancreatic juice, urine, and mucus—contain valuable information about chemical composition, biomarkers, bacterial colonies, and other key components. More...

This information aids researchers in understanding the mechanisms of various diseases, including cancer, and monitoring patients' health. Wireless mobile robots at the millimeter scale have shown promise in navigating confined spaces to collect these fluids due to their small size and agile movement. However, these devices have lacked the ability to sample liquids effectively because of the absence of efficient triggering and sealing mechanisms at such small scales. Researchers have now addressed this gap by developing technology for sampling body fluids in narrow and complex spaces, which could enable early detection of diseases like cancer.

A research team at Vanderbilt University (Nashville, TN, USA) has developed millimeter-scale soft capsules made of hydrogel-and-elastomer hybrids, which are controlled using external magnetic fields. These devices, according to the researchers, can be delivered and retrieved via a thin catheter and are capable of navigating tubular structures that are otherwise inaccessible to catheters. The soft capsules are coated with a specialized wetting property that enables them to efficiently pump liquids inside. As reported in Science Advances, the integration of on-demand triggering, sampling, and sealing mechanisms, along with agile group locomotion, allowed the team to demonstrate precise control of these soft capsules. They successfully navigated and sampled body fluids in a phantom and ex vivo animal organ, guided by ultrasound and X-ray medical imaging.

“The millimeter-scale soft capsules introduced in this work open avenues for minimally invasive and targeted liquid biopsy in confined spaces such as the pancreas duct, enabling early disease diagnosis and providing insights into disease development through the sampling, retrieval, and analysis of abundant chemicals within organs,” said Xiaoguang Dong, assistant professor of mechanical and biomedical engineering at Vanderbilt University, who led the research.

Related Links:
Vanderbilt University


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Radial Immunodiffusion Assay
Radial Immunodifusion - C3 ID
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.